Artivion, Inc. Subsidiaries: 38 by Jurisdiction (AORT) | Sharpnel
ARTIVION, INC. (AORT)
NYSE · Common Stock · Surgical & Medical Instruments & Apparatus
One email a week from me: what it filed, which 13F holders added or cut, where its scores stand. Free.
Corporate structure
38 entities across 28 jurisdictions, 1 in offshore financial centres. Read directly from the company’s own 10-K EX-21 filed 2026-02-18 — see the exhibit.
Which other public companies file entities in the same places:
Subsidiaries of ARTIVION, INC. as disclosed in its SEC filing
Entity
Jurisdiction
Note
Artivion Chile SpA
Chile
Artivion Colombia SAS
Colombia
Artivion Cyprus Limited
Cyprus
offshore centre
Artivion EMEA GmbH
Germany
Artivion France S.A.S.
France
Artivion Hellas Single Member Ltd.
Greece
Artivion Hong Kong, Limited
Hong Kong
Artivion India Private Limited
India
Artivion Italy s.r.l.
Italy
Artivion LATAM Holdings Spain, SLU
Spain
Artivion Malaysia, Sdn. Bhd.
Financial health
Two standard screens, computed from the XBRL in FY2025 against FY2024. Every test shows the numbers behind it — a score with its inputs hidden is a number you cannot check.
Piotroski F-score
7 / 9
PASSReturn on assets positiveROA 1.1%
PASSOperating cash flow positiveOCF 40M
PASSReturn on assets improving-1.7% → 1.1%
PASSCash flow exceeds earningsOCF 40M vs NI 10M
PASSLong-term debt ratio falling39.8% → 24.3% of assets
FAILCurrent ratio improving4.34 → 3.53
FAILNo share dilution42M → 47M shares
PASSGross margin improving64.0% → 64.4%
PASSAsset turnover improving0.49× → 0.50×
Altman Z-score
2.13grey
Bankruptcy-risk screen combining working capital, retained earnings, operating income, market value against liabilities, and asset turnover. Above 2.99 is the safe zone; below 1.81 is distress.
Six-year record
Year
Revenue
Net income
Free cash flow
Gross margin
Shares
FY2020
$253.2M
−$16.7M
$5.0M
66.3%
37,861,000
FY2021
$298.8M
−$14.8M
−$15.7M
66.1%
38,983,000
FY2022
$313.8M
−$19.2M
−$14.2M
64.5%
40,032,000
FY2023
$354.0M
−$30.7M
$11.4M
64.7%
40,743,000
FY2024
$388.5M
−$13.4M
$11.0M
64.0%
41,676,000
Ownership flow
13 institutions tracked — 7 added, 4 reduced, 1 opened a new position. Index money added 886,693 shares while active managers cut 1,656,035.
Institutional holders of ARTIVION, INC. and their share-count change
Manager
Kind
Shares
Change
Value
FMR LLC
Active fund
16,691
−1,946,780
$380,877
BlackRock, Inc.
Index
7,348,508
+674,491
$167.7M
CITADEL ADVISORS LLC
Hedge fund
1,143,170
+315,576
$26.1M
STATE STREET CORP
Index
1,993,187
+135,136
Identity
CIK
0000784199
LEI
549300YTKV8DMSMG6K81
FIGI
BBG000BMLVJ6
SIC
3841 · Surgical & Medical Instruments & Apparatus
Incorporated
DE
Headquarters
KENNESAW, GA
Ownership
Institutional
95.6%
Institutions
301
Insiders
4.3%
Ownership percentages are a vendor aggregate, not a filing — unlike everything else on this page.
Other surgical & medical instruments & apparatus companies
How many subsidiaries does ARTIVION, INC. file with the SEC?
38, listed in its most recent exhibit 21. They are incorporated across 28 jurisdictions, led by Chile, Colombia, Cyprus. 1 of them sit in offshore financial centres. That exhibit is filed with the company's annual report and is the company's own list, not an estimate.
Is ARTIVION, INC. financially healthy?
ARTIVION, INC. scores 7 out of 9 on the Piotroski F-score. Its Altman Z-score puts it in the grey zone. Every test and the numbers behind it are shown above, so the arithmetic is checkable rather than something you have to take on trust.
Who are the largest institutional holders of ARTIVION, INC.?
Among the managers tracked here, the biggest positions as of the 2026-Q3 13F filings are BlackRock, Inc. (adding), MORGAN STANLEY (adding), STATE STREET CORP (adding). Direction is the change in share count against that manager's own previous filing; managers with no prior filing are left out rather than counted as new buyers.
This page is one panel of the terminal
The structure map above is the Corporate Blueprint, and in the desktop it is interactive — click any entity to re-centre the map on it and walk the ownership chain. It sits alongside the screener, the scorecard and the filings lab on one desk, on your machine.
Sourced from SEC EDGAR primary filings. Figures are as reported by the company and are not investment advice. Scores are standard published screens computed from those filings; every input is shown above so you can check the arithmetic.
Malaysia
Artivion México, S.A. de C.V.
Mexico
Artivion New Zealand
New Zealand
Artivion Polska Sp. z.o.o.
Poland
Artivion Spain, s.r.l.
Spain
Artivion Taiwan Co. Limited
Taiwan
Artivion UK Ltd.
England and Wales
Ascyrus Medical GmbH
Germany
Ascyrus Medical LLC
Florida
AuraZyme Pharmaceuticals, Inc.
Florida
CryoLife Asia Pacific, PTE. Ltd
Singapore
CryoLife Beijing Medical Device Ltd.
China
CryoLife Canada, Inc.
Canada
CryoLife Germany HoldCo GmbH
Germany
CryoLife Germany TopCo GmbH
Germany
CryoLife International, Inc.
Florida
CryoLife Korea Co., Ltd.
Korea
CryoLife Medical (Australia) Co. Pty, Ltd.
Australia
CryoLife Medical (Thailand) Co., Ltd.
Thailand
CryoLife Vietnam Co., Ltd.
Vietnam
Jolly Buyer Acquisition GmbH
Switzerland
JOTEC do Brasil Ltda.
Brazil
JOTEC GmbH
Germany
JOTEC Sales GmbH
Switzerland
JOTEC UK Ltd.
England
On-X Life Technologies Holdings, Inc.
Delaware
On-X Life Technologies, Inc.
Delaware
Valve Special Purpose Co., LLC
Delaware
Cash conversion
408.3%
Share count change
13.2%
FY2025
$441.3M
$9.8M
$839,000
64.4%
47,162,000
$45.5M
MORGAN STANLEY
Active fund
2,645,243
+87,282
$60.4M
WELLINGTON MANAGEMENT GROUP LLP
Active fund
1,175,221
−85,058
$26.8M
GEODE CAPITAL MANAGEMENT, LLC
Index
1,191,363
+77,066
$27.2M
BANK OF AMERICA CORP /DE/
Active fund
586,868
+65,431
$13.4M
RENAISSANCE TECHNOLOGIES LLC
Hedge fund
10,900
−56,927
$248,738
JPMORGAN CHASE & CO
Active fund
31,348
−53,351
$716,615
AQR CAPITAL MANAGEMENT LLC
Hedge fund
32,175
+17,792
$734,234
Point72 Asset Management, L.P. holds a position with no prior filing to compare against, so its change is unknown rather than zero — and it is left out of the totals above.
From 13F filings, which cover institutions managing over $100m and are filed up to 45 days after the quarter ends — so this is a considered position, not a live one, and it is not the whole shareholder register.